Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypoxia and Stem Cell Content as Aggression Factors in Prostate Cancer
NCT02095249Active, not recruiting
- Sponsor
- University Health Network
- Start
- Sep 2014
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pimonidazole in prostate cancer (PCa), sponsored by University Health Network. Primary endpoint: Quantitation of pimonidazole staining at 3 years. Started Sep 2014; status: active, not recruiting.
02
Drugs
pimonidazole
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02095249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095249.